Prevention and Rehabilitation After Heart Transplantation: A Clinical Consensus Statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a Section of ESOT.


Journal

Transplant international : official journal of the European Society for Organ Transplantation
ISSN: 1432-2277
Titre abrégé: Transpl Int
Pays: Switzerland
ID NLM: 8908516

Informations de publication

Date de publication:
2024
Historique:
received: 26 04 2024
accepted: 30 05 2024
medline: 17 7 2024
pubmed: 17 7 2024
entrez: 17 7 2024
Statut: epublish

Résumé

Little is known either about either physical activity patterns, or other lifestyle-related prevention measures in heart transplantation (HTx) recipients. The history of HTx started more than 50 years ago but there are still no guidelines or position papers highlighting the features of prevention and rehabilitation after HTx. The aims of this scientific statement are (i) to explain the importance of prevention and rehabilitation after HTx, and (ii) to promote the factors (modifiable/non-modifiable) that should be addressed after HTx to improve patients' physical capacity, quality of life and survival. All HTx team members have their role to play in the care of these patients and multidisciplinary prevention and rehabilitation programmes designed for transplant recipients. HTx recipients are clearly not healthy disease-free subjects yet they also significantly differ from heart failure patients or those who are supported with mechanical circulatory support. Therefore, prevention and rehabilitation after HTx both need to be specifically tailored to this patient population and be multidisciplinary in nature. Prevention and rehabilitation programmes should be initiated early after HTx and continued during the entire post-transplant journey. This clinical consensus statement focuses on the importance and the characteristics of prevention and rehabilitation designed for HTx recipients.

Identifiants

pubmed: 39015154
doi: 10.3389/ti.2024.13191
pii: 13191
pmc: PMC11250379
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

13191

Informations de copyright

Copyright © 2024 Simonenko, Hansen, Niebauer, Volterrani, Adamopoulos, Amarelli, Ambrosetti, Anker, Bayes-Genis, Ben Gal, Bowen, Cacciatore, Caminiti, Cavarretta, Chioncel, Coats, Cohen-Solal, D’Ascenzi, de Pablo Zarzosa, Gevaert, Gustafsson, Kemps, Hill, Jaarsma, Jankowska, Joyce, Krankel, Lainscak, Lund, Moura, Nytrøen, Osto, Piepoli, Potena, Rakisheva, Rosano, Savarese, Seferovic, Thompson, Thum and Van Craenenbroeck.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Maria Simonenko (M)

Cardiopulmonary Exercise Test Research Department, Heart Transplantation Outpatient Department, V. A. Almazov National Medical Research Centre, St. Petersburg, Russia.

Dominique Hansen (D)

REVAL and BIOMED Rehabilitation Research Center, Hasselt University, Hasselt, Belgium.
Heart Centre Hasselt, Jessa Hospital, Hasselt, Belgium.

Josef Niebauer (J)

University Institute of Sports Medicine, Prevention and Rehabilitation, Paracelsus Medical University, Salzburg, Austria.

Maurizio Volterrani (M)

Cardio-Pulmonary Department, IRCCS San Raffaele Roma, Rome, Italy.

Stamatis Adamopoulos (S)

Heart Failure and Heart Transplantation Unit, Onassis Cardiac Surgery Center, Athens, Greece.

Cristiano Amarelli (C)

Department of Cardiac Surgery and Transplants, Monaldi Hospital, Azienda dei Colli, Naples, Italy.

Marco Ambrosetti (M)

Cardiovascular Rehabilitation Unit, ASST Crema, Santa Marta Hospital, Rivolta D'Adda, Italy.

Stefan D Anker (SD)

Department of Cardiology (CVK), Berlin Institute of Health Center for Regenerative Therapies (BCRT), German Centre for Cardiovascular Research (DZHK) Partner Site Berlin, Charité Universitätsmedizin Berlin, Berlin, Germany.

Antonio Bayes-Genis (A)

University Hospital Germans Trias and Pujol de Badalona, Badalona, Spain.

Tuvia Ben Gal (T)

Heart Failure Unit, Cardiology Department, Rabin Medical Center, Petah Tikva and Sackler, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

T Scott Bowen (TS)

School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds, United Kingdom.

Francesco Cacciatore (F)

Department of Translational Medicine, University of Naples "Federico II", Naples, Italy.

Giuseppe Caminiti (G)

Cardio-Pulmonary Department, IRCCS San Raffaele Roma, Rome, Italy.

Elena Cavarretta (E)

Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Rome, Italy.
Mediterranea Cardiocentro, Naples, Italy.

Ovidiu Chioncel (O)

Emergency Institute for Cardiovascular Diseases "Prof. C. C. Iliescu", Bucharest, Romania.
University of Medicine Carol Davila, Bucharest, Romania.

Andrew J S Coats (AJS)

Heart Research Institute, Sydney, NSW, Australia.

Alain Cohen-Solal (A)

Cardiology Department, University of Paris, INSERM UMRS-942, Hopital Lariboisiere, AP-HP, Paris, France.

Flavio D'Ascenzi (F)

Division of Cardiology, Department of Medical Biotechnologies, University of Siena, Siena, Italy.

Carmen de Pablo Zarzosa (C)

Department of Cardiology, Ramón y Cajal University Hospital, Madrid, Spain.

Andreas B Gevaert (AB)

Research Group Cardiovascular Diseases, Genetics, Pharmacology and Physiopathology of Heart, Blood Vessels and Skeleton (GENCOR) Department, University of Antwerp, Antwerp, Belgium.
Department of Cardiology, Antwerp University Hospital, Edegem, Belgium.

Finn Gustafsson (F)

Department of Cardiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Hareld Kemps (H)

Department of Cardiology, Maxima Medical Centre, Eindhoven, Netherlands.
Department of Industrial Design, Eindhoven University of Technology, Eindhoven, Netherlands.

Loreena Hill (L)

School of Nursing and Midwifery, Queen's University Belfast, Belfast, United Kingdom.

Tiny Jaarsma (T)

Department of Health, Medicine and Caring Science, Linköping University, Linköping, Sweden.
Julius Center, University Medical Center Utrecht, Utrecht, Netherlands.

Ewa Jankowska (E)

Department of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland.

Emer Joyce (E)

Department of Cardiology, Mater University Hospital, Dublin, Ireland.
School of Medicine, University College Dublin, Dublin, Ireland.

Nicolle Krankel (N)

Universitätsmedizin Berlin Campus Benjamin Franklin Klinik für Kardiologie Charite, Berlin, Germany.

Mitja Lainscak (M)

General Hospital Murska Sobota, Murska Sobota, Slovenia.

Lars H Lund (LH)

Department of Medicine, Karolinska Institutet and Heart and Vascular Theme, Karolinska University Hospital, Stockholm, Sweden.

Brenda Moura (B)

Armed Forces Hospital, Porto, Portugal.
Centre for Health Technologies and Services Research, Faculty of Medicine of University of Porto, Porto, Portugal.

Kari Nytrøen (K)

Department of Cardiology, Oslo University Hospital Rikshospitalet, Oslo, Norway.

Elena Osto (E)

Division of Physiology and Pathophysiology, Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Medical University of Graz, Graz, Austria.
Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.

Massimo Piepoli (M)

Dipartimento Scienze Biomediche per la Salute, Universita' Degli Studi di Milan, Milan, Italy.
Cardiologia Universitaria, IRCCS Policlinico San Donato, Milan, Italy.

Luciano Potena (L)

University Hospital of Bologna, Bologna, Italy.

Amina Rakisheva (A)

Department of Cardiology, Scientific Institution of Cardiology and Internal Diseases, Almaty, Kazakhstan.
Department of Cardiology, Kapshagai City Hospital, Almaty, Kazakhstan.

Giuseppe Rosano (G)

St. George's Hospital NHS Trust University of London, London, United Kingdom.

Gianluigi Savarese (G)

Division of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.

Petar M Seferovic (PM)

Faculty of Medicine and Heart Failure Center, University of Belgrade, Belgrade University Medical Center, Belgrade, Serbia.

David R Thompson (DR)

School of Nursing and Midwifery, Queen's University Belfast, Belfast, United Kingdom.

Thomas Thum (T)

Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School and Fraunhofer Institute for Toxicology and Experimental Research, Hannover, Germany.

Emeline M Van Craenenbroeck (EM)

Research Group Cardiovascular Diseases, Genetics, Pharmacology and Physiopathology of Heart, Blood Vessels and Skeleton (GENCOR) Department, University of Antwerp, Antwerp, Belgium.
Department of Cardiology, Antwerp University Hospital, Edegem, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH